[
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C9569"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Cisplatin/Cyclophosphamide Regimen"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C9569",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A regimen consisting of cisplatin and cyclophosphamide that may be used in the treatment of ovarian cancer."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C63522",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C63522",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C63522",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C63522",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95690"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Discrete Set Organization Name Data Type"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95690",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A data type comprised of a collection of a discrete set of organization names."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C42645",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C42645",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C42645",
      "http://purl.obolibrary.org/obo/NCIT_C92722",
      "http://purl.obolibrary.org/obo/NCIT_C20189"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C42645",
      "http://purl.obolibrary.org/obo/NCIT_C92722",
      "http://purl.obolibrary.org/obo/NCIT_C20189"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95691"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Discrete Set Person Name Data Type"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95691",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A data type comprised of a collection of a discrete set of person names."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C42645",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C42645",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C42645",
      "http://purl.obolibrary.org/obo/NCIT_C92722",
      "http://purl.obolibrary.org/obo/NCIT_C20189"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C42645",
      "http://purl.obolibrary.org/obo/NCIT_C92722",
      "http://purl.obolibrary.org/obo/NCIT_C20189"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95692"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Expression Physical Quantity Data Type"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95692",
    "type": [
      "class",
      "entity"
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C42645",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C42645",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C42645",
      "http://purl.obolibrary.org/obo/NCIT_C92722",
      "http://purl.obolibrary.org/obo/NCIT_C20189"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C42645",
      "http://purl.obolibrary.org/obo/NCIT_C92722",
      "http://purl.obolibrary.org/obo/NCIT_C20189"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95693"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Interval Point in Time Integer Data Type"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95693",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A data type comprised of a set of consecutive values of an ordered point in time integer datatype."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C42645",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C42645",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C42645",
      "http://purl.obolibrary.org/obo/NCIT_C92722",
      "http://purl.obolibrary.org/obo/NCIT_C20189"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C42645",
      "http://purl.obolibrary.org/obo/NCIT_C92722",
      "http://purl.obolibrary.org/obo/NCIT_C20189"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95694"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Non-negative Integer to Non-negative Integer Ratio Data Type"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95694",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A data type comprised of a non-negative integer divided by another non-negative integer."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C42645",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C42645",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C42645",
      "http://purl.obolibrary.org/obo/NCIT_C92722",
      "http://purl.obolibrary.org/obo/NCIT_C20189"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C42645",
      "http://purl.obolibrary.org/obo/NCIT_C92722",
      "http://purl.obolibrary.org/obo/NCIT_C20189"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95695"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Non-negative Integer to Physical Quantity Time Ratio Data Type"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95695",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A data type comprised of a non-negative integer divided by a physical quantity expressed in units of time."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C42645",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C42645",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C42645",
      "http://purl.obolibrary.org/obo/NCIT_C92722",
      "http://purl.obolibrary.org/obo/NCIT_C20189"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C42645",
      "http://purl.obolibrary.org/obo/NCIT_C92722",
      "http://purl.obolibrary.org/obo/NCIT_C20189"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95696"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Trivial Name Data Type"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95696",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A data type comprised of the words or language units by which an entity is known."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C42645",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C42645",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C42645",
      "http://purl.obolibrary.org/obo/NCIT_C92722",
      "http://purl.obolibrary.org/obo/NCIT_C20189"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C42645",
      "http://purl.obolibrary.org/obo/NCIT_C92722",
      "http://purl.obolibrary.org/obo/NCIT_C20189"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95697"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Uncertain Range Physical Quantity Time Data Type"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95697",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A data type comprised of an uncertain range of integers that are comprised of a measured physical entity with units that describe a period of time."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C42645",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C42645",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C42645",
      "http://purl.obolibrary.org/obo/NCIT_C92722",
      "http://purl.obolibrary.org/obo/NCIT_C20189"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C42645",
      "http://purl.obolibrary.org/obo/NCIT_C92722",
      "http://purl.obolibrary.org/obo/NCIT_C20189"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95698"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95698",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A radioimmunoconjugate containing the murine IgG1 anti-CD45 monoclonal antibody (MoAb) BC8 labeled with yttrium 90 (Y90), with potential immunotherapeutic activity. Yttrium Y 90 anti-CD45 monoclonal antibody BC8 binds to CD45 antigen, a receptor protein-tyrosine phosphatase expressed on the surface of both normal and malignant hematopoietic cells. After binding and internalization by CD45-expressing tumor cells, this agent may deliver a cytotoxic dose of beta radiation."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129819",
      "http://purl.obolibrary.org/obo/NCIT_C1511"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129819",
      "http://purl.obolibrary.org/obo/NCIT_C1511"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129819",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1511",
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C2124"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129819",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1511",
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C2124"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95699"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "TLR7 Agonist ANA773 Tosylate"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95699",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The tosylate salt form of ANA773, a Toll-Like Receptor 7 (TLR7) agonist prodrug with potential immunostimulating activity. Upon oral administration, ANA773 is metabolized into its active form that binds to and activates TLR7, thereby stimulating dendritic cells (DCs) and enhancing natural killer cell (NK) cytotoxicity. This activation results in the production of proinflammatory cytokines, including interferon alpha, and enhanced antibody-dependent cellular cytotoxicity (ADCC). TLR7 is a member of the TLR family, which plays a fundamental role in pathogen recognition and activation of innate immunity."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C177176",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C177176",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C177176",
      "http://purl.obolibrary.org/obo/NCIT_C177174",
      "http://purl.obolibrary.org/obo/NCIT_C2139",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C177176",
      "http://purl.obolibrary.org/obo/NCIT_C177174",
      "http://purl.obolibrary.org/obo/NCIT_C2139",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C957"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "10-Deacetyltaxol"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C957",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An analog of paclitaxel with antineoplastic activity.  10-Deacetyltaxol binds to and stabilizes the resulting microtubules, thereby inhibiting microtubule disassembly which results in cell- cycle arrest at the G2/M phase and apoptosis."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1490",
      "http://purl.obolibrary.org/obo/NCIT_C67437"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1490",
      "http://purl.obolibrary.org/obo/NCIT_C67437"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1490",
      "http://purl.obolibrary.org/obo/NCIT_C860",
      "http://purl.obolibrary.org/obo/NCIT_C552",
      "http://purl.obolibrary.org/obo/NCIT_C718",
      "http://purl.obolibrary.org/obo/NCIT_C1913",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C616",
      "http://purl.obolibrary.org/obo/NCIT_C67437",
      "http://purl.obolibrary.org/obo/NCIT_C25974",
      "http://purl.obolibrary.org/obo/NCIT_C273",
      "http://purl.obolibrary.org/obo/NCIT_C186664",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1490",
      "http://purl.obolibrary.org/obo/NCIT_C860",
      "http://purl.obolibrary.org/obo/NCIT_C552",
      "http://purl.obolibrary.org/obo/NCIT_C718",
      "http://purl.obolibrary.org/obo/NCIT_C1913",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C616",
      "http://purl.obolibrary.org/obo/NCIT_C67437",
      "http://purl.obolibrary.org/obo/NCIT_C25974",
      "http://purl.obolibrary.org/obo/NCIT_C273",
      "http://purl.obolibrary.org/obo/NCIT_C186664",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C9570"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "CHAD Regimen"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C9570",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A regimen consisting of hexamethylmelamine (altretamine), cyclophosphamide, doxorubicin, and cisplatin that may be used in the treatment of ovarian cancer."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C63522",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C63522",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C63522",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C63522",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95700"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Anticachexia Agent MT-102"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95700",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A small molecule with potential anticachexia activity. The anticachexia agent MT-102 may increase protein synthesis and decrease muscle protein breakdown. This may result in improved body weight, muscle mass and may improve weakness and fatigue associated with cancer-related cachexia."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1935",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1935",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1935",
      "http://purl.obolibrary.org/obo/NCIT_C78281",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1935",
      "http://purl.obolibrary.org/obo/NCIT_C78281",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95701"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Ribociclib"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95701",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally available cyclin-dependent kinase (CDK) inhibitor targets at cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. Ribociclib specifically inhibits CDK4 and 6, thereby inhibiting retinoblastoma (Rb) protein phosphorylation. Inhibition of Rb phosphorylation prevents CDK-mediated G1-S phase transition, thereby arresting the cell cycle in the G1 phase, suppressing DNA synthesis and inhibiting cancer cell growth. Overexpression of CDK4/6, as seen in certain types of cancer, causes cell cycle deregulation."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C192741",
      "http://purl.obolibrary.org/obo/NCIT_C192742"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C192741",
      "http://purl.obolibrary.org/obo/NCIT_C192742"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C192741",
      "http://purl.obolibrary.org/obo/NCIT_C2185",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C61074",
      "http://purl.obolibrary.org/obo/NCIT_C1404",
      "http://purl.obolibrary.org/obo/NCIT_C192742"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C192741",
      "http://purl.obolibrary.org/obo/NCIT_C2185",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C61074",
      "http://purl.obolibrary.org/obo/NCIT_C1404",
      "http://purl.obolibrary.org/obo/NCIT_C192742"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95702"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "JAK2 Inhibitor BMS-911543"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95702",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally available small molecule targeting a subset of Janus-associated kinase (JAK) with potential antineoplastic activity. JAK2 inhibitor BMS-911543 selectively inhibits JAK2, thereby preventing the JAK/STAT (signal transducer and activator of transcription) signaling cascade, including activation of STAT3. This may lead to an induction of tumor cell apoptosis and a decrease in cellular proliferation. JAK2, often upregulated or mutated in a variety of cancer cells, mediates STAT3 activation and plays a key role in tumor cell proliferation and survival."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C125450",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C125450",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C125450",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C172200",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C125450",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C172200",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95703"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Palifosfamide Tromethamine"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95703",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A synthetic mustard compound of the tromethamine (tris) salt of palifosfamide (Isophosphamide mustard), with potential antineoplastic activity. As the stabilized active metabolite of ifosfamide, palifosfamide irreversibly alkylates and crosslinks DNA through GC base pairs, resulting in irreparable 7-atom interstrand crosslinks. This leads to an inhibition of DNA replication and ultimately cell death. Unlike ifosfamide, this agent is not metabolized to acrolein or chloroacetaldehyde, metabolites associated with bladder and CNS toxicities. In addition, because palifosfamide does not require activation by aldehyde dehydrogenase, it may overcome the tumor resistance seen with ifosfamide. Stabilization with tris instead of lysine further increases stability and may further decrease nephrotoxicity."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C697",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C697",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C697",
      "http://purl.obolibrary.org/obo/NCIT_C2114",
      "http://purl.obolibrary.org/obo/NCIT_C1590",
      "http://purl.obolibrary.org/obo/NCIT_C2842",
      "http://purl.obolibrary.org/obo/NCIT_C186664",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C697",
      "http://purl.obolibrary.org/obo/NCIT_C2114",
      "http://purl.obolibrary.org/obo/NCIT_C1590",
      "http://purl.obolibrary.org/obo/NCIT_C2842",
      "http://purl.obolibrary.org/obo/NCIT_C186664",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95704"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Anti-ANG2 Monoclonal Antibody MEDI-3617"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95704",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A fully human IgG1 monoclonal antibody against angiopoietin 2 (ANG2), with potential antiangiogenic activity. Anti-ANG2 monoclonal antibody MEDI-3617 binds to Ang2 and interferes with the interaction between Ang2 and its receptor TEK tyrosine kinase (Tie2), thereby resulting in the disruption of vascular remodeling. This may inhibit angiogenesis and may eventually lead to an inhibition of tumor cell proliferation."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C20401"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C20401"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95705"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "SVN53-67/M57-KLH Peptide Vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95705",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A peptide vaccine containing a 15-mer peptide (DLAQMFFCFKELEGW), with C to M alteration at amino acid position 57, derived from the anti-apoptosis protein survivin, and conjugated with keyhole limpet hemocyanin (KLH), with potential immunopotentiating and antineoplastic activities. Upon subcutaneous administration of SVN53-67/M57-KLH peptide vaccine, this peptide is able to bind both HMC class I and II molecules and may activate the immune system to mount a cytotoxic T-lymphocyte (CTL) as well as a T-helper cell response against survivin-expressing cancer cells. This may result in decreased tumor cell proliferation and ultimately tumor cell death. Survivin, a member of the inhibitor of apoptosis (IAP) family, expressed during embryonic development while absent in most normal adult cells, is upregulated in a variety of human cancers; its expression in tumors is associated with a more aggressive phenotype, decreased survival, and increased resistance to chemotherapy. KLH may enhance immune recognition and may promote an enhanced response. As SVN53-67 is weakly immunogenic in humans, the M57 alteration may lead to greater affinity towards HLA-A*0201 and thus an enhanced antitumor immune response."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C1752"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C1752"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1752"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1752"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95706"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Antibiotic SQ109"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95706",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally available, acid-stable diamine antibiotic, with potential antimicrobial activity against a variety of bacteria including Helicobacter pylori (H. pylori) and Mycobacterium tuberculosis (M. Tuberculosis). As an ethambutol analogue with asymmetric structure, SQ109 does not act on the same target as ethambutol. However, this agent interferes with cell wall synthesis, thereby causing weakening of the cell wall and ultimately cell lysis."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C258",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C258",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C258",
      "http://purl.obolibrary.org/obo/NCIT_C254",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C258",
      "http://purl.obolibrary.org/obo/NCIT_C254",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95707"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Anti-PSMA Monoclonal Antibody-MMAE Conjugate"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95707",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An antibody-drug conjugate (ADC) containing a fully human monoclonal antibody directed against prostate-specific membrane antigen (PSMA), conjugated via a stable, enzyme-cleavable linker to monomethylauristatin E (MMAE), an auristatin derivative and a potent microtubule inhibitor, with potential antineoplastic activity.  The monoclonal antibody moiety of this conjugate selectively binds to PSMA, a protein which is abundantly expressed on the surface of metastatic and hormone-refractory prostate cancer cells. Upon internalization and proteolytic cleavage, MMAE binds to tubulin and inhibits its polymerization, resulting in G2/M phase arrest and tumor cell apoptosis."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C201544",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C201544",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C201544",
      "http://purl.obolibrary.org/obo/NCIT_C129823",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C176017",
      "http://purl.obolibrary.org/obo/NCIT_C163758"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C201544",
      "http://purl.obolibrary.org/obo/NCIT_C129823",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C176017",
      "http://purl.obolibrary.org/obo/NCIT_C163758"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95708"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Bermekimab"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95708",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A human immunoglobulin (Ig) G1 monoclonal antibody directed against interleukin-1 alpha (IL-1a) and derived from human B-lymphocytes that were obtained from a natural human immune response against IL-1a, with potential antineoplastic, anti-inflammatory, anti-cachectic and anti-angiogenic activities. Upon administration, bermekimab targets, binds to and neutralizes IL-1a thereby preventing IL-1a activity. This prevents IL-1a-mediated inflammation, tumorigenesis and angiogenesis. In addition, bermekimab may abrogate IL-1a-mediated cachexia and stimulate metabolic activity in the central nervous system (CNS). IL-1a, an inflammatory mediator expressed on monocytes, platelets and overexpressed by certain tumors, plays a key role in the promotion of tumor cell growth, metastasis and invasion."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C20401"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C20401"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95709"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Prohibitin-Targeting Peptide 1"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95709",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A chimeric, 25-mer peptide that targets prohibitin, with potential antineoplastic activity. Prohibitin-targeting peptide 1 (prohibitin-TP01) consists of a fat-targeting motif (CKGGRAKDC), two repeats of a proapoptotic peptide motif (KLAKLAK) and a GG linker. This peptide binds specifically to prohibitin in the white adipose vasculature; upon receptor-mediated cell internalization, the ligand/receptor complex triggers apoptosis and results in ablation of white fat. Destruction of white fat may potentially have positive consequences for men with prostate cancer since a high level of white fat has been implicated as a critical contributing factor in poor prostate cancer outcome. Prohibitin, a multifunctional membrane-associated protein that is thought to regulate cell survival and growth, has been shown by immunohistochemical analysis to be expressed in the membrane of endothelial cells in white adipose tissue."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C129824",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C129824",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C9571"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "DVB Regimen"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C9571",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A regimen consisting of cisplatin, bleomycin and vindesine that may be used in the treatment of non-small cell lung cancer."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C63360",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C63360",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C63360",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C63360",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95710"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Labetuzumab Govitecan"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95710",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An antibody-drug conjugate (ADC) containing labetuzumab, a mildly reduced, anti-CEACAM5 humanized monoclonal antibody, conjugated to the potent topoisomerase I inhibitor SN-38, with antineoplastic activity.  The monoclonal antibody moiety of labetuzumab govitecan selectively binds to carcinoembryonic cell adhesion molecule 5 (CEACAM5), which is abundantly expressed on the surface of a majority of solid tumors. Upon internalization and proteolytic cleavage, SN-38, the active metabolite of irinotecan, inhibits the activity of topoisomerase I in the tumor cells, eventually inhibiting both DNA replication and transcription and leading to tumor cell apoptosis."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C201549",
      "http://purl.obolibrary.org/obo/NCIT_C204999"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C201549",
      "http://purl.obolibrary.org/obo/NCIT_C204999"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C201549",
      "http://purl.obolibrary.org/obo/NCIT_C129823",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C200043",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C204999"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C201549",
      "http://purl.obolibrary.org/obo/NCIT_C129823",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C200043",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C204999"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95711"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Iodine I 124-labeled Hsp90 Inhibitor PUH71"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95711",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A radioconjugate containing the purine scaffold heat shock protein 90 (Hsp90) inhibitor PUH71 labeled with the radioisotope iodine I 124, with positron emitting activity. Hsp90 inhibitor PUH71 is thought to bind to cytosolic Hsp90 and the endoplasmic reticulum paralogue gp96 (HSP90B1), thereby inhibiting its molecular chaperone function and promoting the degradation of the oncogenic signaling proteins. This induces caspase-dependent apoptosis. The iodine I 124 moiety can be visualized using Positron emission tomography (PET) imaging, thereby allowing an assessment of the accumulation of PUH71 in vivo, particularly in tumors. Hsp90, a chaperone protein upregulated in a variety of tumor cells, regulates the folding, stability and degradation of many oncogenic signaling proteins."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95712"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Nesvacumab"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95712",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A fully human monoclonal antibody directed against angiopoietin 2 (ANG2) with potential antiangiogenic and antineoplastic activities. Nesvacumab binds to ANG2 and interferes with the interaction between Ang2 and its receptor TEK tyrosine kinase (Tie2), which may inhibit tumor cell angiogenesis and tumor cell proliferation. ANG2 is upregulated in a variety of cancer cell types and plays a crucial role in angiogenesis."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C20401"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C20401"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95713"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Endoxifen Hydrochloride"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95713",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The hydrochloride salt and the z (cis-) stereoisomer of endoxifen with potential antineoplastic activity. Endoxifen, the active metabolite of tamoxifen, competitively inhibits the binding of estradiol to estrogen receptors, thereby preventing the receptor from binding to the estrogen-response element on DNA and thus reducing DNA synthesis. Unlike tamoxifen, however, which relies on CYP2D6 activity for its conversion to the active metabolite endoxifen, the direct administration of endoxifen bypasses the CYP2D6 route. As CYP2D6 activity can vary widely among individuals due to genetic CYP2D6 polymorphisms, endoxifen is therefore theoretically more potent and more uniform in its bioavailability across patient populations."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1821",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1821",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1821",
      "http://purl.obolibrary.org/obo/NCIT_C1892",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C203677",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C481",
      "http://purl.obolibrary.org/obo/NCIT_C129818",
      "http://purl.obolibrary.org/obo/NCIT_C147908",
      "http://purl.obolibrary.org/obo/NCIT_C547",
      "http://purl.obolibrary.org/obo/NCIT_C483",
      "http://purl.obolibrary.org/obo/NCIT_C548"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1821",
      "http://purl.obolibrary.org/obo/NCIT_C1892",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C203677",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C481",
      "http://purl.obolibrary.org/obo/NCIT_C129818",
      "http://purl.obolibrary.org/obo/NCIT_C147908",
      "http://purl.obolibrary.org/obo/NCIT_C547",
      "http://purl.obolibrary.org/obo/NCIT_C483",
      "http://purl.obolibrary.org/obo/NCIT_C548"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95714"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Timolol Maleate Gel Forming Solution"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95714",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A gel forming solution containing the maleate salt of timolol, a propanolamine derivative and a non-selective beta-adrenergic antagonist, with intraocular pressure-reducing activity. Although the precise mechanism of action of timolol's ocular hypotensive action is not clearly established at this time, studies suggest that it may be the result of decreased aqueous humor production (possibly by reduction of blood flow to the ciliary processes and cAMP synthesis) as well as a slight increase in outflow facility. Timolol gel-forming solution can potentially be used topically as well, in the prevention of the neoangiogenesis that may occur following pulsed dye laser treatment of port wine stains."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C29576",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C29576",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C29576",
      "http://purl.obolibrary.org/obo/NCIT_C72900",
      "http://purl.obolibrary.org/obo/NCIT_C29747",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C29576",
      "http://purl.obolibrary.org/obo/NCIT_C72900",
      "http://purl.obolibrary.org/obo/NCIT_C29747",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95715"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Autologous CD8 Positive PBL Sensitized to Drosophila Cell-Presented Melanoma Peptides"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95715",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A preparation of autologous CD8+ (cytotoxic) human peripheral blood lymphocytes (PBLs) sensitized to Drosophila cell-presented melanoma peptides, with potential immunostimulating and antineoplastic activities. Autologous CD8+ T-lymphocytes, isolated from a melanoma patient, are exposed in vitro to melanoma peptide-pulsed HLA-A2-expressing Drosophila cells, expanded, and reintroduced into the patient; these tumor-reactive T-cells may stimulate a host immune response against tumor cells expressing the melanoma antigens, resulting in tumor cell lysis. Drosophila cells, which do not express any native MHC molecules, have been shown to potently stimulate tumor-reactivity in vitro from human peripheral blood lymphocytes (PBL) when stably transfected with human MHC molecules and appropriate adhesion and costimulatory molecules."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C28681"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C28681"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C142078",
      "http://purl.obolibrary.org/obo/NCIT_C28681"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C142078",
      "http://purl.obolibrary.org/obo/NCIT_C28681"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95716"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "CYL-02 Plasmid DNA"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95716",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A gene transfer preparation of a plasmid DNA encoding mouse somatostatin receptor subtype 2 (sst2) and a fusion protein of human deoxycytidine kinase (DCK) and uridine monophosphate kinase (UMK), complexed to a synthetic polycationic carrier, polyethylenimine, with antineoplastic adjuvant application. Upon administration, CYL-02 plasmid DNA expresses DCK::UMK fusion protein that converts gemcitabine into its toxic phosphorylated metabolite. Expression of sst2 protein by this agent could induce both antioncogenic and local antitumor bystander effects. A loss of sst2 gene expression often is found in pancreatic and colorectal cancers, and is the receptor for somatostatin which negatively regulates a number of processes such as epithelial cell proliferation. Combination effects of these gene products allows for less chemotherapy to cause tumor cell lysis in not only the original tumor, but in distant tumors as well."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C61199"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C61199"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C61199"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C61199"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95717"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Liposomal SN-38"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95717",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The liposomal formulation of SN-38 (7-ethyl-10-hydroxy-camptothecin), a biologically active metabolite of the prodrug irinotecan, with potential antineoplastic activity. SN-38 binds to and inhibits topoisomerase I by stabilizing the cleavable complex between topoisomerase I and DNA, resulting in DNA breaks, inhibition of DNA replication, and apoptosis. SN-38 has been reported to exhibit up to 1,000-fold more cytotoxic activity against various cancer cells in vitro than irinotecan. The liposomal formulation of SN-38 increases the solubility of SN-38, which is a relatively insoluble compound, and improves the pharmacodynamic profile as compared to SN-38 alone."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C2843",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C2843",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2843",
      "http://purl.obolibrary.org/obo/NCIT_C1904",
      "http://purl.obolibrary.org/obo/NCIT_C1748",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2843",
      "http://purl.obolibrary.org/obo/NCIT_C1904",
      "http://purl.obolibrary.org/obo/NCIT_C1748",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95718"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Liposomal c-raf Antisense Oligonucleotide"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95718",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The liposomal formulation of a c-raf-1 antisense oligonucleotide, with potential antineoplastic activity. Liposomal c-raf antisense oligonucleotide targets the translation initiation site of human c-raf-1 mRNA, thereby blocking the expression and production of Raf-1 protein and thus inhibit tumor cell growth and development. Raf-1 plays a key role in the RAF/MEK/ERK signaling pathway, which regulates mammalian cell proliferation and growth. The liposomal formulation increases the solubility of the c-raf antisense oligonucleotide, thus improving its pharmacodynamic profile."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1291",
      "http://purl.obolibrary.org/obo/NCIT_C129825"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1291",
      "http://purl.obolibrary.org/obo/NCIT_C129825"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1291",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C471"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1291",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C471"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95719"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Tarextumab"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95719",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A monoclonal antibody directed against the Notch receptor with potential antineoplastic activity. Tarextumab binds to Notch on the cell surface, thereby inhibiting Notch-mediated signaling and gene transcription, which may impede tumor angiogenesis. Notch receptors are important for cell-cell communication, which involves gene regulation mechanisms that control multiple cell differentiation processes during embryonic and adult life. Dysregulated Notch signaling is implicated in many diseases including T-ALL (T-cell acute lymphoblastic leukemia), CADASIL (Cerebral Autosomal Dominant Arteriopathy with Sub-cortical Infarcts and Leukoencephalopathy), MS (Multiple Sclerosis), and many other disease states."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C20401"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C20401"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C9572"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Cyclophosphamide/Dacarbazine/Vincristine"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C9572",
    "type": [
      "class",
      "entity"
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C61063",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C61063",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C61063",
      "http://purl.obolibrary.org/obo/NCIT_C62633",
      "http://purl.obolibrary.org/obo/NCIT_C12218"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C61063",
      "http://purl.obolibrary.org/obo/NCIT_C62633",
      "http://purl.obolibrary.org/obo/NCIT_C12218"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95720"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "ERa36 Modulator Icaritin"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95720",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A metabolite of icariin, a principal flavonoid glycoside in Herba Epimedii (a traditional Chinese medicine herb used in treating osteoporosis) with potential antineoplastic activity. ERa36 modulator icaritin selectively binds to a novel variant of estrogen receptor alpha, a36, and mediates a membrane-initiated \"nongenomic\" signaling pathway, which is linked to activate signaling pathways like the MAPK/ERK and the PI3K/Akt pathways. This agent induces cell cycle arrest at G1, or G2/M arrest depending upon the dose. Consistently with G1 arrest, icaritin increases protein expressions of pRb, p27(Kip1) and p16(Ink4a), while decreasing phosphorylated pRb, Cyclin D1 and CDK4. 40% of ER-negative breast cancer tumors express high levels of ERa36, and this subset of patients is less likely to benefit from tamoxifen treatment compared with those with ERa66-positive/ERa36-negative tumors."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1821",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1821",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1821",
      "http://purl.obolibrary.org/obo/NCIT_C1892",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C203677",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C481",
      "http://purl.obolibrary.org/obo/NCIT_C129818",
      "http://purl.obolibrary.org/obo/NCIT_C147908",
      "http://purl.obolibrary.org/obo/NCIT_C547",
      "http://purl.obolibrary.org/obo/NCIT_C483",
      "http://purl.obolibrary.org/obo/NCIT_C548"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1821",
      "http://purl.obolibrary.org/obo/NCIT_C1892",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C203677",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C481",
      "http://purl.obolibrary.org/obo/NCIT_C129818",
      "http://purl.obolibrary.org/obo/NCIT_C147908",
      "http://purl.obolibrary.org/obo/NCIT_C547",
      "http://purl.obolibrary.org/obo/NCIT_C483",
      "http://purl.obolibrary.org/obo/NCIT_C548"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95721"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Anti-HB-EGF Monoclonal Antibody KHK2866"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95721",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A proprietary fucose-free monoclonal antibody directed against human heparin-binding EGF-like growth factor (HBEGF) with potential antineoplastic activity. Anti-HB-EGF Monoclonal Antibody KHK2866 binds to HBEGF, thereby blocking its binding to the EGF receptors. This prevents EGF receptor activation and the subsequent induction of cell growth signaling. HBEGF is mitogenic for fibroblasts and smooth muscle and may be involved in macrophage-mediated cellular proliferation. The fucose-free monoclonal antibodies enhance antigen dependent cellular cytotoxicity (ADCC), and increase binding affinity to the Fc Receptor to overcome genetic polymorphism."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C20401"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C20401"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95722"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "MUC1-targeted Peptide GO-203-2C"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95722",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An optimized small peptide drug candidate targeting epithelial mucin (MUC1) with antineoplastic activity. MUC1-targeted peptide GO-203-2C interacts with oncoprotein MUC1 C-terminal subunit on the cell surface, thereby impeding cell-cell interactions, signaling, and metastasis. MUC1 antigen, a membrane bound glycoprotein expressed by most glandular and ductal epithelial cells, is over-expressed in many diverse human carcinomas including those of the breast, prostate, lung, colon, pancreas, and ovary, and has been associated with poor prognosis."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1752",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1752",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1752",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1752",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95723"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "PI3K Inhibitor ZSTK474"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95723",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally available, s-triazine derivative, ATP-competitive phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity. PI3K inhibitor ZSTK474 inhibits all four PI3K isoforms. Inhibiting the activation of the PI3K/AKT kinase (or protein kinase B) signaling pathway results in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Dysregulated PI3K signaling may contribute to tumor resistance to a variety of antineoplastic agents. This agent does not induce apoptosis but rather induces strong G(0)/G(1) arrest, which might contribute to its favorable efficacy in tumor cells."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C2152"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C2152"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C2152",
      "http://purl.obolibrary.org/obo/NCIT_C1404",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C1742"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C2152",
      "http://purl.obolibrary.org/obo/NCIT_C1404",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C1742"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95724"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "MTF-1 Inhibitor APTO-253 HCl"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95724",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The hydrochloride salt of a small molecule inhibitor of human metal-regulatory transcription factor 1 (MTF-1) with potential antitumor activity. MTF-1 inhibitor APTO-253 inhibits MTF-1 activity and thereby induces the expression of MTF-1 dependent tumor suppressor factor Kruppel like factor 4 (KLF4). This subsequently leads to the downregulation of cyclin D1, blocking cell cycle progression and proliferation. This agent also causes decreased expression of genes involved in tumor hypoxia and angiogenesis."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1742",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1742",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95725"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Carbon C 11 N-desmethyl-Loperamide"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95725",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A radiopharmaceutical containing N-desmethyl loperamide (dLop) labeled with carbon 11 (11C), used to measure the activity of efflux transporter P-glycoprotein (P-gp) in positron emission tomography (PET). Upon administration, carbon C 11 N-desmethyl-loperamide acts as a substrate for the efflux transporter P-gp. Upon uptake by P-gp at the blood-brain barrier (BBB) and subsequent PET imaging, this radioligand may allow for prediction of P-gp function and expression in brain tumor patients. As P-gp activity may influence response to therapy, measuring P-gp activity may be beneficial when choosing chemotherapy. P-gp, encoded by the MDR-1 gene and a member of the ATP-binding cassette (ABC) superfamily of transmembrane transporters, is overexpressed by some MDR tumors and may contribute to multidrug resistance to chemotherapy."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95726"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Lucitanib"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95726",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A novel dual inhibitor targeting human vascular endothelial growth factor receptors (VEGFRs) and fibroblast growth factor receptors (FGFRs) with antiangiogenic activity. Lucitanib inhibits VEGFR-1, -2, -3 and FGFR-1, -2 kinases in the nM range, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation, and the induction of tumor cell death. Both VEGFRs and FGFRs belong to the family of receptor tyrosine kinases that may be upregulated in various tumor cell types."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C93259",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C93259",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C93259",
      "http://purl.obolibrary.org/obo/NCIT_C163953",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404",
      "http://purl.obolibrary.org/obo/NCIT_C471"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C93259",
      "http://purl.obolibrary.org/obo/NCIT_C163953",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404",
      "http://purl.obolibrary.org/obo/NCIT_C471"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95727"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "pUMVC3-hIGFBP-2 Multi-epitope Plasmid DNA Vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95727",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A recombinant plasmid DNA vaccine containing mammalian expression vector, pUMVC3, encoding epitopes of human Insulin-Like Growth Factor-Binding Protein 2 (hIGFBP-2) with potential antineoplastic activity. Upon vaccination, pUMVC3-hIGFBP-2 multi-epitope plasmid DNA vaccine may produce IGFBP-2 that binds to cell surface, likely via integrin complexes. This results in the dephosphorylation of the focal adhesion-kinase (FAK) and of the p42/44 MAP-kinases, thereby inactivating them; both kinases are involved in cell growth regulation. Furthermore, IGFBP-2 promotes de-adhesion of the cells in a dose-dependent manner, hence impeding cell proliferation. The primary effect of IGFBPs appears to be modulation of IGF activity and control of IGF-mediated cell growth and metabolism."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C39619"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C39619"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C39619",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C39619",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95728"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Anti-CEA BiTE Monoclonal Antibody AMG211"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95728",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A recombinant, proprietary bispecific T-cell engagers (BiTE) antibody directed against human carcinoembryonic antigen (CEA), with potential immunostimulating and antineoplastic activities. Anti-CEA BiTE monoclonal antibody AMG211 possesses two antigen-recognition sites, one for CEA and one for the CD3 complex, a group of T cell surface glycoproteins that complex with the T cell receptor (TCR). This bispecific monoclonal antibody brings CEA-expressing tumor cells and cytotoxic T lymphocytes (CTLs) and helper T lymphocytes (HTLs) together, which may result in the CTL- and HTL-mediated cell death of CEA-expressing cells. CEA, a tumor associated antigen, is overexpressed in many cancer types, including gastrointestinal, breast, non-small cell lung, and thyroid cancers."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C201282",
      "http://purl.obolibrary.org/obo/NCIT_C2456"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C201282",
      "http://purl.obolibrary.org/obo/NCIT_C2456"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C201282",
      "http://purl.obolibrary.org/obo/NCIT_C203828",
      "http://purl.obolibrary.org/obo/NCIT_C112883",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C28227",
      "http://purl.obolibrary.org/obo/NCIT_C1454",
      "http://purl.obolibrary.org/obo/NCIT_C2456",
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C200043",
      "http://purl.obolibrary.org/obo/NCIT_C163758"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C201282",
      "http://purl.obolibrary.org/obo/NCIT_C203828",
      "http://purl.obolibrary.org/obo/NCIT_C112883",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C28227",
      "http://purl.obolibrary.org/obo/NCIT_C1454",
      "http://purl.obolibrary.org/obo/NCIT_C2456",
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C200043",
      "http://purl.obolibrary.org/obo/NCIT_C163758"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95729"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Merestinib"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95729",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally available, small molecule inhibitor of the proto-oncogene c-Met (also known as hepatocyte growth factor receptor (HGFR)) with potential antineoplastic activity. Merestinib selectively binds to c-Met, thereby inhibiting c-Met phosphorylation and disrupting c-Met signal transduction pathways. This may induce cell death in tumor cells overexpressing c-Met protein or expressing constitutively activated c-Met protein. This agent has potent anti-tumor efficacy in mono and combination therapy in a broad range of cancers. c-Met, a receptor tyrosine kinase overexpressed or mutated in many tumor cell types, plays key roles in tumor cell proliferation, survival, invasion, metastasis, and tumor angiogenesis."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C143099"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C143099"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C143099",
      "http://purl.obolibrary.org/obo/NCIT_C164000",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C143099",
      "http://purl.obolibrary.org/obo/NCIT_C164000",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C9573"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "CVP Regimen"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C9573",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A regimen consisting of cyclophosphamide, vincristine and prednisone that may be used to treat Castleman disease, post-transplant lymphoproliferative disorders, indolent forms of non-Hodgkin lymphoma and chronic lymphocytic leukemia."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C191727",
      "http://purl.obolibrary.org/obo/NCIT_C63442",
      "http://purl.obolibrary.org/obo/NCIT_C63443"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C191727",
      "http://purl.obolibrary.org/obo/NCIT_C63442",
      "http://purl.obolibrary.org/obo/NCIT_C63443"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C191727",
      "http://purl.obolibrary.org/obo/NCIT_C191723",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218",
      "http://purl.obolibrary.org/obo/NCIT_C63442",
      "http://purl.obolibrary.org/obo/NCIT_C186719",
      "http://purl.obolibrary.org/obo/NCIT_C186724",
      "http://purl.obolibrary.org/obo/NCIT_C63443",
      "http://purl.obolibrary.org/obo/NCIT_C173974"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C191727",
      "http://purl.obolibrary.org/obo/NCIT_C191723",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218",
      "http://purl.obolibrary.org/obo/NCIT_C63442",
      "http://purl.obolibrary.org/obo/NCIT_C186719",
      "http://purl.obolibrary.org/obo/NCIT_C186724",
      "http://purl.obolibrary.org/obo/NCIT_C63443",
      "http://purl.obolibrary.org/obo/NCIT_C173974"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95730"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Mucoadhesive Oral Wound Rinse"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95730",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A viscous, oral hydrogel rinse intended for the management of oral mucositis/stomatitis. Mucoadhesive oral wound rinse consists of purified water, glycerin, benzyl alcohol, sodium saccharin, carbomer homopolymer A, potassium hydroxide, citric acid, polysorbate 60 and phosphoric acid. Upon gargling and rinsing with this solution, it forms a soothing protective hydrogel coating over the oral mucosa, thereby potentially preventing or reducing chemotherapy-induced mucositis."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C78275",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C78275",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C78275",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C78275",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95731"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Antrodia cinnamomea Supplement"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95731",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A dietary supplement containing extract from the medicinal fungus Antrodia cinnamomea with potential antiangiogenic, hepatoprotective and antioxidant activities. The components in Antrodia cinnamomea supplement are rather complex, however, rich in triterpenoids, polysaccharides, nucleosides (adenosine) nucleic acids, superoxide dismutase, other small molecular weight proteins and steroid like compounds. Neutral sugars in this supplement show inhibitory activity on endothelial tube formation, while maleimide and maleic anhydride derivative components in the extract, such as antrodin B and antrodin C and their metabolites, exhibit significant cytotoxic effects on tumor cells and hepatitis C virus."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1505",
      "http://purl.obolibrary.org/obo/NCIT_C1931"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1505",
      "http://purl.obolibrary.org/obo/NCIT_C1931"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1505",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C1931",
      "http://purl.obolibrary.org/obo/NCIT_C1907",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C274"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1505",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C1931",
      "http://purl.obolibrary.org/obo/NCIT_C1907",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C274"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95732"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Emibetuzumab"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95732",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A humanized IgG4 monoclonal antibody directed against human hepatocyte growth factor receptor (HGFR or c-MET) with potential antineoplastic activity. Emibetuzumab binds to c-MET, thereby preventing the binding of HGF to its receptor c-Met and subsequent activation of the HGF/c-Met signaling pathway. This may result in cell death in c-Met-expressing tumor cells. c-Met, a receptor tyrosine kinase overexpressed or mutated in many tumor cell types, plays a key role in cancer cell growth, survival, angiogenesis, invasion, and metastasis."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C164001"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C164001"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C164001",
      "http://purl.obolibrary.org/obo/NCIT_C164000",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C164001",
      "http://purl.obolibrary.org/obo/NCIT_C164000",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C95733"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Talazoparib"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C95733",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally bioavailable inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) with potential antineoplastic activity. Talazoparib selectively binds to PARP and prevents PARP-mediated DNA repair of single strand DNA breaks via the base-excision repair pathway. This enhances the accumulation of DNA strand breaks, promotes genomic instability and eventually leads to apoptosis. PARP catalyzes post-translational ADP-ribosylation of nuclear proteins that signal and recruit other proteins to repair damaged DNA and is activated by single-strand DNA breaks."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C62554",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C62554",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C62554",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C62554",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  }
]